Inactive Instrument
ONCODESIGN Share Price
Stocks
ALONC
FR0011766229
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Aidan Synnott
CEO | Chief Executive Officer | 48 | 10/04/2025 |
Fabrice Viviani
CEO | Chief Executive Officer | - | 04/11/2022 |
Arnaud Lafforgue
DFI | Director of Finance/CFO | - | 23/04/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Karine Lignel
BRD | Director/Board Member | 58 | 13/05/2008 |
Kamel Besseghir
BRD | Director/Board Member | 78 | 02/02/2014 |
Aline Aubertin
BRD | Director/Board Member | - | 23/06/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 17/12/22 | Buy | Chief Executive Officer | 18,480 | 0.2673% | ||
| 24/10/22 | Sell | Chief Technology Officer | 17,640 | 0.2576% | ||
| 24/10/22 | Sell | Chief Financial Officer | 21,230 | 0.3100% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -0.14% | - | - | 105M | |
| -2.54% | -2.84% | -1.90% | +14.52% | 50.35B | |
| -0.40% | +1.03% | +439.20% | +499.20% | 45.2B | |
| -1.42% | +2.30% | +45.46% | +19.36% | 44.71B | |
| -1.22% | -2.31% | +12.40% | +71.48% | 41.24B | |
| +0.53% | -1.36% | +16.04% | +48.23% | 33.08B | |
| -0.21% | +9.14% | - | - | 17.81B | |
| -0.35% | -1.56% | +22.59% | +116.19% | 16.56B | |
| -1.01% | +0.50% | +15.83% | +27.98% | 14.82B | |
| -1.65% | -1.03% | +77.75% | +37.63% | 14B | |
| Average | -0.83% | +0.49% | +78.42% | +104.33% | 30.86B | |
| Weighted average by Cap. | -1.04% | +0.26% | +94.35% | +121.44% |
Employees
236
